Commercialize Western Tech in Asian Market
Bridge Point Solutions
Bridge Point Capital is a growth-focused cross-border Private Equity and Strategic Advisory firm with a unique expertise in monetizing and marketing disruptive Healthcare technology. We are able to help western companies access the Asia market as well as help Asian firms develop business opportunities in the U.S.
Cross-border Market Entry
Strategic Alliances & Planning
Innovative Financing Strategy
Health-Tech Commercialization
Third Party Reimbursement
Licensing
Licensing Timeline
Bridge Point Advisory utilizes our deep Asia expertise, proprietary network of U.S healthcare and financial institutions to help Asian pharmaceutical distributors to commercialize Western products. We aim to create long-term value for our clients from assisting with partner sourcing all the way to deal structuring and deal closing
2 weeks
2 - 4 weeks
1 month
Research on Positioning & China Market
Identify Prospective Partners
Partnership Materials & Outreach
Partnership Due Diligence
1 month
Deal Structuring & Economics
3 - 4 weeks
Transaction Negotiation
1 - 2 months
Transaction Closing
1 month
CONTACT US
152 W57th Street, Carnegie Hall Tower, 49th Floor, New York
NY, 10019
​
.jpg)